泰尔米沙坦加安洛迪平作为新诊断的印度高血压患者首选的初始组合:一个专家的共识声明
Jamshed Dalal1, Santanu Guha2, Yerramareddy Vijaya Chandra Reddy3
1Consulting Cardiologist, Department of Cardiac Sciences, Kokilaben Dhirubhai Ambani Hospital & Medical Research Institute, Mumbai, Maharashtra, India.
概括
对于印度新诊断的高血压患者来说,为了有效控制血压,通常需要联合治疗. 推泰尔米沙坦加上安洛迪平作为首选的初始治疗方法,以改善心血管结果.
科学领域:
- 心脏病学 心脏病学
- 高血压管理 高血压管理
- 临床实践指南 临床实践指南
背景情况:
- 高血压 (HTN) 是心血管疾病和死亡率的主要全球风险因素.
- 在全球范围内,血压控制不良的情况仍然存在,印度只有22.5%的患者得到控制.
- 有效的早期治疗对于管理HTN和降低相关健康风险至关重要.
研究的目的:
- 在新诊断的印度高血压患者中建立初始双重组合治疗的共识建议.
- 为了指导临床医生选择高血压的有效初始治疗方法.
- 为了解决印度缺乏初始组合治疗的具体指导方针.
主要方法:
- 一个由100名高血压专家组成的核心小组制定了关键问题.
- 使用Delphi和儿童健康和营养研究计划 (CHNRI) 的混合方法方法被采用.
- 建议使用利克尔特等级 (1-9) 进行评分,接受要求三分之二的专家得分≥7.
主要成果:
- 对于大多数新诊断的印度高血压患者来说,可能需要组合治疗.
- 这种方法可以带来更好的高血压管理和改善的临床结果.
- 根据专家的共识,特尔米沙坦加安洛迪平成为首选的初始组合.
结论:
- 在许多新诊断的印度高血压患者中,初始组合治疗对于有效的血压控制至关重要.
- 推的组合疗法旨在改善心血管结果.
- 泰尔米沙坦加安洛迪平被确定为印度新诊断高血压的首选初始治疗策略.
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
715
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
715
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Antihypertensive Drugs: Direct Renin Inhibitors
601
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
601
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
155
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
155
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
620
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
620
Antihypertensive Drugs: Thiazide-Class Diuretics
611
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
611


